ENANTA PHARMACEUTICALS, INC Increase (Decrease) in Restricted Cash
ENANTA PHARMACEUTICALS, INC (ENTA) reported Increase (Decrease) in Restricted Cash of $172.00 thousand for the 12-month period ending 2015-09-30, per its 10-K filed 2015-12-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2016-08-09
- ENANTA PHARMACEUTICALS, INC increase (decrease) in restricted cash for the quarter ending 2015-09-30 was $0.00.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in restricted cash for the quarter ending 2015-06-30 was $0.00.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in restricted cash for the quarter ending 2012-09-30 was $0.00.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in restricted cash for the quarter ending 2012-06-30 was $0.00.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in restricted cash for fiscal 2015 was $172.00K.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in restricted cash for fiscal 2012 was -$1.14M, a 361.47% decline from fiscal 2011.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in restricted cash for fiscal 2011 was $436.00K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2015-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | $0.00 derived: sum of 2 quarters · filed 2016-08-09 | $172.00K 10-K · filed 2015-12-11 | |
| 2015-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | $172.00K 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $172.00K 10-Q · filed 2016-05-10 | |||
| 2012-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-11 | $0.00 derived: sum of 2 quarters · filed 2014-12-11 | -$1.14M 10-K · filed 2014-12-11 | |
| 2012-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-12 | -$1.14M 10-Q · filed 2013-08-12 | ||
| 2012-03-31 | -$1.14M 10-Q · filed 2013-05-15 | |||
| 2011-09-30 | $436.00K 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |